Integrated AI platform combining enterprise-grade pathology software, cloud support, and low-cost hardware with local deployment options for data ownership, security, and methods transparency. Validated biomarker solutions for biopharma and healthcare providers enabling molecular state prediction, risk estimation, and multimodal integration to accelerate drug development and guide cancer treatment selection.